Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now ...

Particles as different as soap bubbles and ball bearings can be made to arrange themselves in exactly the same way, according ...

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / SMX (NASDAQ:SMX) isn’t in the sustainability business. It’s in the truth ...

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Every company reaches a turning point when its technology stops being promise and starts becoming structure. SMX (NASDAQ:SMX) is there now. The ...

A newly developed mouse model enables real-time visualization of RNA Polymerase II (RNAP2) during DNA transcription, as ...

Pictures of DNA often look very tidy—the strands of the double helix neatly wind around each other, making it seem like ...

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Every industry reaches a moment when proof stops being optional. For SMX (NASDAQ:SMX), that moment has arrived. What began as molecular science has ...

There comes a point in every company's journey when innovation stops being an idea and becomes infrastructure. SMX ...

Explore how Google’s Gemini 3.0 Pro AI is transforming creativity, education, and technology with unmatched speed and ...

Partnerships intend to make “proof” a currency across plastics, precious metals, textiles, and rare earth sectors NEW YORK, ...